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ABSTRACT
Objective: To assess the efficacy of Single-dose antibiotic prophylaxis against postpartum endomyo-
metritis in high-risk cesarean secti6n patients.
Design: Patients were administered one of three single-dose antibiotic regimens following um-
bilical cord clamping after cesarean section delivery.
Setting: Prospective randomized trial at a university-based hospital.
Patients: The study evaluated 293 consenting women undergoing cesarean section who had
either experienced labor for a duration of -> 6 hr or rupture of amniotic membranes.
Main outcome measures: Development of postpartum endomyometritis.
Results: The incidence of postpartum endomyometritis was 7/95 (7.4%) following the ampicillin/
sulbactam regimen, 14/98 14.3%) after the cefazolin regimen, and 11/99 (11.1%) after the cefotetan
regimen. There was no significant difference in postpartum infection among the three study arms.
In addition, the incidence of endomyometritis in the three single-dose study arms was not higher
than previously noted in studies where three doses of antibiotic were administered.
Conclusion: Single-dose antibiotic prophylaxis should replace the standard triple-dose therapy for
uninfected women undergoing cesarean section who are at risk for postoperative endomyometritis.
Ampicillin/sulbactam, cefazolin, and cefotetan are all reasonable antibiotic choices for single-dose
therapy. Infect. Dis. Obstet. Gynecol. 6:220-223, 1998. (C) 1998 Wiley-Liss, Inc.
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he current incidence of birth by cesarean sec-
tion in the United States is greater than 20%.
The postoperative infection rate after cesarean sec-
tion ranges from 10% to 90%, and both the inci-
dence and severity of infection is known to be
higher in patients undergoing operative vs. vaginal
delivery. 1,z The need for antibiotic prophylaxis
during high-risk cesarean deliveries has been
firmly established by multiple investigators who
have demonstrated a significant reduction in post-
operative endomyometritis with such therapy.3-5
In a trial of three-dose intravenous antibiotic pro-
phylaxis and antibiotic lavage at New York Hospi-
tal, the incidence of postoperative endomyometri-
tis was significantly reduced from 32% to 12% in
patients undergoing cesarean section in labor. 8
Multiple-dose prophylaxis was the previous stan-
dard of care at New York Hospital in patients un-
dergoing cesarean section following rupture of
membranes (ROM) or labor. At the time of the
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present study, the use of single-dose therapy after
umbilical cord clamping at other institutions had
been shown to have efficacy equal to three-dose
regimens for prophylaxis against infection.6,7 The
current study was undertaken to evaluate a single-
dose prophylactic antibiotic regimen for operative
deliveries.
SUBJECTS AND METHODS
From July 1988 to November 1990, 756 gravid
women admitted to The New York Hospital in
labor or having had ROM for 6 hours were enrolled
in a prospective randomized trial to evaluate the
efficacy of single-dose antibiotic prophylaxis with
one of three antibiotic agents. Written consent was
obtained on admission to the hospital. If the pa-
tient underwent cesarean section, she was random-
ized to receive intravenously either 1.5 g of ampi-
cillin/sulbactam (A/S) (Unasyn (R), Pfizer, New York,
NY), g of the first-generation cephalosporin ce-
fazolin (Ansef% Smithkline Beecham, Pittsburgh,
PA), or g of the second-generation cephalosporin
cefotetan (Cefotan(R), Zeneca, Wilmington, DE) af-
ter umbilical cord clamping.
Criteria for the study included being in labor
and/or having ROM for at least 6 hours, as these
were considered risk factors for the development of
endomyometritis. Exclusion criteria were as fol-
lows: <18 years of age, known allergy to penicillin
or cephalosporin antibiotics, antibiotic therapy
within 72 hours prior to hospital admission, history
of group B [3-streptococcal infection, prophylactic
antibiotic therapy for medical indications, prior use
of steroid therapy for underlying medical illness or
enhancement of fetal lung maturity, or clinical evi-
dence of chorioamnionitis at the time of cesarean
section. Other than complete blood count (CBC)
and evaluation of a voided urine sample for protein
and sugar, no other laboratory or microbiologic
evaluations were performed preoperatively. Post-
operative lochia cultures were obtained if the pa-
tient had febrile morbidity or symptoms suggestive
of infection. Febrile morbidity was diagnosed if the
patient had an oral temperature above 39C on two
occasions 6 hours apart more than 24 hours follow-
ing the operative delivery. Endomyometritis was
diagnosed if febrile morbidity was associated with
foul-smelling lochia or uterine tenderness or if no
other sources of infection were found on clinical or
laboratory examination.
The incidence of endomyometritis was evalu-
ated as it related to the following variables: the
particular antibiotic administered, the service as-
signment of the patient (ward vs. private), race,
number of hours of labor, number of hours of
ROM, whether oxytocin was used, number of vagi-
nal examinations performed, whether the cesarean
was done for an emergent indication (e.g., fetal dis-
tress or vaginal bleeding), the type of anesthesia
administered, length of surgery, and whether the
patient experienced postoperative anemia (i.e., he-
matocrit <28%). The Student t-test and chi-square
analysis were used, and differences were consid-
ered significant at P < 0.05.
RESULTS
Of the 756 patients who consented to participate
on admission, 300 (39.6%) ultimately underwent
cesarean section. One hundred of these patients
were randomized to receive A/S, 100 to cefazolin,
and 100 to cefotetan. Five patients from the A/S
group, two from the cefazolin group, and one from
the cefotetan group were considered unevaluable,
as they did not meet the protocol criteria. The rea-
sons were as follows: two patients inadvertently re-
ceived the prophylaxis for vaginal delivery rather
than cesarean section, two patients had positive
group B 13-streptococcal cultures and had simulta-
neously received intravenous ampicillin prophy-
laxis, two patients had elevated temperatures at the
time of cesarean section, and two patients inadver-
tently received two prophylactic doses of cefoxitin
in the early postoperative period. Thus, evaluable
patients included 95 who received MS, 98 who re-
ceived cefazolin, and 99 who received cefotetan.
Epidemiologic and clinical parameters are given
in Tables and 2. The ratio of Caucasian to non-
Caucasian patients was 1.2:1, and the ratio of pri-
vate to ward service assignment was 1.9:1. The per-
centage of patients who received oxytocin was
52.7%. Regional anesthesia was administered to
91.4%, and the remainder received general anes-
thesia. There were no statistically significant dif-
ferences in the preoperative parameters among the
three study arms. Indications for cesarean section
in all patients, in order of highest frequency, were
as follows: failure to progress/cephalopelvic dispro-
portion, fetal distress, malpresentation, previous
cesarean section, multiple gestation, or other indi-
cations, such as placenta previa, active herpes sim-
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TABLE I. Epidemiologic and clinical parameters of
study group
Age (year) 31.2
Weight (Ib) 160.5
Hematocrit (%)
Preoperative 36.0
Postoperative 32.7
Estimated gestational age (wk) 38.6
Ruptured membranes (hr) 7.3
Labor (hr) 12.7
Sterile vaginal exams (n) 4.6
Surgical time (min) 54.1
Length of stay (day) 5.2
TABLE 3. Incidence of endomyometritis following
prophylaxis with ampicillin/sulbactam, cefazolin,
or cefotetan
Incidence of
postpartum Side
endomyometritis effects
Study arm n No. (%) No.
Ampicillin/sulbactam 95 7 (7.36)
Cefazolin 98 14 (14.26) 0
Cefotetan 99 (I I. I) 2
aValues are expressed as means unless otherwise indicated. No signifi-
cant difference was noted within the three treatment arms.
TABLE 2. Patient distribution (n 292)
Race Non-Caucasian Caucasian
132 160
Service assignment Ward Private
101 191
Labor augmentation Oxytocin augmentation No oxytocin
154 138
Anesthesia Regional General
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plex infection, and severe preeclampsia. The indi-
cations were evenly distributed among the antibi-
otic groups. All patients experienced labor and/or
ROM of at least 6 hours’ duration.
The incidence of postpartum endomyometritis
was 7/95 (7.4%) in the A/S group, 14/98 (14.3%) in
the cefazolin group, and 11/100 (11.0%) in the ce-
fotetan group (Table 3). These differences were
not statistically different, with P values ranging
from 0.19 to 0.63. The incidence of endomyome-
tritis in the treatment groups was markedly lower
than the 32% rate previously observed at The New
York Hospital in patients who had not received
antibiotic prophylaxis for cesarean section.8 There
were no life-threatening postoperative complica-
tions and no increased lengths of hospital stay in
the patients with endomyometritis. Three patients
experienced transient untoward effects. A single
A/S-treated patient reported mild leg pain of un-
certain etiology that lasted 2 days. She was ob-
served and recovered spontaneously. Of the ce-
fotetan-treated patients, there were two adverse re-
actions. One patient had mild chest pain on the left
side felt to be musculoskeletal in nature. This pain
resolved with conservative management. The
other patient developed a pruritic rash that re-
solved following two doses of diphenhydramine
hydrochloride. No adverse reactions were reported
in the cefazolin group.
Clinical epidemiologic parameters in all study
patients were examined in an attempt to establish
contributing factors to endomyometritis (Table 4).
Non-Caucasian patients and those on the ward ser-
vice were 2.1 times more likely to develop endo-
myometritis. Fifteen percent of the non-Caucasian
group and 16.8% of the ward-service group devel-
oped endomyometritis, compared with 7% of Cau-
casian patients and 7.8% of the private-service pa-
tients (P 0.04 and 0.03, respectively).
A patient undergoing cesarean section under
general anesthesia at The New York Hospital was
three times as likely to develop endomyometritis as
one receiving regional anesthesia. Twenty-eight
percent of patients who had general anesthesia de-
veloped endometrial infection, compared with
9.3% of the patients undergoing regional anesthe-
sia (P 0.01). Surgery lasting hour or more was
associated with a 2.7-fold increased risk of devel-
oping endomyometritis over procedures performed
in less than 1 hour (18.7% vs. 7.0%, respectively; P
0.007). Postoperative anemia, defined as a hemat-
ocrit < 28%, increased the risk of postoperative en-
dometrial infection threefold, with an incidence of
25.7% if the hematocrit was less than 28% vs. 8.9%
if the hematocrit was ->28% (P 0.01). A preop-
erative weight of >-200 lb was associated with a
2.5-fold increased risk of postoperative endomyo-
metritis, compared with a preoperative weight <
200 lb (P 0.02). Factors not found to be associated
with an increased incidence of endomyometritis in-
cluded labor longer than 12 hours, ROM longer
than 8 hours, more than six sterile vaginal exams,
use of oxytocin, or emergent indication for cesarean
section (P 0.53 to 0.98).
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TABLE 4. Incidence of endomyometritis by factor
Race Non-Caucasian Caucasian P
15% 7% O.004
Service assignment Ward Private
16.8% 7.8% 0.03
Anesthesia General Regional
28% 9.3% .01
Surgery duration >1 hour -< hour
18% 7% 0.007
Postoperative hematocrit < 28% ->28%
25.7% 8.9% 0.006
The findings of the present study as well as
others9-11 suggest that the modified penicillin A/S
may be an effective prophylactic antibiotic for de-
creasing the incidence of postoperative endomyo-
metritis in women undergoing high-risk cesarean
sections. This agent and first- and second-
generation cephalosporins administered as a single
dose appear to represent suitable alternative thera-
pies for prophylaxis against postpartum endomyo-
metritis.
DISCUSSION
Single-dose antibiotic prophylaxis resulted in a low
incidence of postpartum endomyometritis when
used in high-risk patients undergoing cesarean sec-
tion. No statistically significant difference in infec-
tion rate was noted regardless of whether patients
received A/S (1.5 g), the first-generation cephalo-
sporin cefazolin (1 g), or the second-generation
cephalosporin cefotetan (1 g). The power of this
study is such that approximately 550 additional
subjects would be needed to verify that there was
no difference in infection rate between the groups.
The P values observed when comparing the inci-
dence of endomyometritis in the three study arms
ranged from 0.19-0.630, which did not suggest a
trend toward differences in infection rates among
the groups.
Univariate analysis implicated several clinical
epidemiologic factors as predictors of endomyome-
tritis. Risk factors associated with an increased in-
cidence of postoperative endomyometritis in-
cluded non-Caucasian ethnicity, ward-service as-
signment, obesity, use of general anesthesia,
prolonged operating time, and the presence of
postoperative anemia. Factors found not to be as-
sociated with an increased incidence of endomyo-
metritis included prolonged labor, prolonged rup-
ture of fetal membranes, a high number of re-
corded vaginal examinations, the use of oxytocin,
and an emergent indication for surgery. Prior stud-
ies have implicated prolonged ROM, many vaginal
exams, and protracted duration of labor in postpar-
tum uterine infection. The mean values for these
three parameters in this study were 7.3 hours, 4.6
exams, and 12.7 hours respectively. Perhaps there
were not enough patients with excessive values
when evaluating these risk factors to see a signifi-
cant influence.
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